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Abstract
In the last decades, cannabinoids, the active constituents of Cannabis sativa L.,
have been attracting a strong interest, regarding the health effects associated with
the use of Cannabis and Cannabis-derived products. The progressive legalization of
this species in several countries has prompted an increasing concern about the
characterization and quantification of cannabinoids in diverse chemotypes of the
plant, as well as the obtained final products. Therewith, Process and Product
Quality Assurance (PPQA) becomes a mandatory practise to verify the Good
Manufacturing Practices (GMP). Gas chromatography is one of the most used
techniques in this sense due to its high attainable resolution. However, sample
complexity and the thermal lability of cannabinoids hinder the analysis. In this
chapter, a fully description of the recent advances in the Cannabis sativa L. analysis
by gas chromatography will be presented, including different approaches that have
come up to solve the obstacles encountered.
Keywords: Cannabis sativa L., hemp, complex matrix, cannabinoids, Terpenoids,
gas chromatography, quality control assurance
1. Introduction
Cannabis sativa L. is the most thoroughly studied and widely used plant from
Central Asia 3000 years before the Christian era. This annual dioecious plant has a
complex chemical composition, including cannabinoids, terpenes, flavonoids,
stilbenoids, fatty acids, alkaloids, carbohydrates, and polyphenols, among others.
Therefore, this plant and its by-products have been widely used in different areas in
the production of ropes, cloth, food or oil, being considered one of the most signif-
icant agricultural crops over the years. Additionally, since the chemical structure of
Δ9-tetrahydrocannabinol (∆9-THC), the main psychoactive compound in Cannabis,
was identified by Mechoulam in the 60s, the studies about the active compounds of
Cannabis increased dramatically and, owing to its bioactive components, Cannabis
has been used for recreational, medicinal and scientific purposes [1]. In recent
years, as a consequence of multiple scientific evidences, the number of countries
around the world where the use of Cannabis is being legalized or decriminalized is
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continuously growing, like many Latin American countries (Uruguay, Peru, Vene-
zuela, Chile, Colombia, Argentina, and Ecuador), different U.S. states, some coun-
tries of Europe (Italy, Czech Republic and Germany) and Canada. In this regulatory
scenario, the most common practice is to use the ∆9-THC content for the discrimi-
nation among industrial or medicinal varieties. However, the classification of Can-
nabis plants regarding this parameter varies depending on the legislation of the
country of origin. While some countries like Switzerland, Uruguay or Colombia
authorize 1.0% of ∆9-THC for medicinal use, more restrictive legislation in the
European Union limits this value to the 0.2% content. It should be noted that
obviously only duly registered and certified varieties could be used [2]. When
talking specifically about medical Cannabis, quality control of cultivars as well as
standardization is a requirement for these applications as they are extremely
important to ensure the health and safety of medical Cannabis users and patients,
being necessary the development of reliable methods to quantify bioactive com-
pounds from Cannabis [3, 4].
Therefore, several chromatographical techniques have been widely used for the
identification and quantification of Cannabis constituents, being gas chromatogra-
phy (GC), especially coupled to mass spectrometry (GC–MS), the most established
technique in forensic and clinical toxicology analyses. Considering the similarities of
their bioactive compounds in their physicochemical properties, chromatographic
separation involves a mandatory step that may be usually considered as time con-
suming. For this reason, different strategies have been implemented increasing the
resolution between isomers and overcoming this problem. In addition, the identifi-
cation of these compounds is possible thanks to the advanced National Institute of
Standards and Technology (NIST) mass-spectral database. In this manner, the
analysis of Cannabis does not require highly sophisticated equipment being appro-
priate for laboratories with reduced instrumental availability. Nevertheless, differ-
ent methods have been reported using high-resolution mass spectrometry allowing
the untargeted analysis of Cannabis samples [5].
Generally, an internal standard (IS) is a nonendogenous compound, which is
naturally similar to the target analyte. In this sense, this methodology is employed
to increase the reproducibility of the quantification when there is a source of errors
during sample analysis. These inaccuracies may be related to random and system-
atic errors, due to sample preparation or even the complexity of the sample, among
other factors. The IS must be added to each sample in a constant amount, as well as
to blank and calibration standards. In this manner, any deviation occasioned during
the analysis of the sample will also affect the IS, correcting the result with the
relation of both signals. For this reason, the selection of the IS is a critical step to
guarantee the precision in the analysis. The stable-isotope labeled IS are the most
suitable when a MS detector is used [6].
Furthermore, derivatization processes are generally required, improving the
chromatographic resolution as well as peak shape of analytes [7]. For this reason,
many derivatization agents have been applied, being the silylation approaches pre-
ferred. These derivatization agents are suitable to volatilize and improve mass
fragmentation properties of active proton-containing groups. Commonly, N, O-bis
(trimethylsilyl) trifluoroacetamide (BSTFA), N-methyl-N-(trimethylsilyl) trifluor-
oacetamide (MSTFA), trimethylchlorosilane (TMCS) or N-tert-butyldimethylsilyl-
N- methyltrifluoroacetamide (MTBSTFA) are utilized [8]. Although this procedure
turns out to be time-consuming, it is worthy since it provides increased sensitivity
and reproducibility [6, 9]. Throughout this chapter, the authors will discuss the
multiple analytical work modalities and methods that have been used to solve all
the inconveniences found in the analysis of Cannabis samples using gas
chromatography.
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2. Cannabinoids
Cannabinoids are the major constituents of Cannabis plant, distributed on aerial
surfaces/leaves and female inflorescences of the plants. These compounds are con-
centrated on resinous secretions produced by glandular trichomes [1, 10]. Their
bioactive compounds are acquiring more notoriety because of their physiological
effects as well as their medicinal properties, which are applied in the treatment of a
wide range of diseases and disorders (e.g. multiple sclerosis, epilepsy, fibromyal-
gia). They are also employed for alleviating the pain induced by some treatment
methods for various diseases, including cancer. Alongside being of great interest for
the patient and medical communities, the European medicinal Cannabis market is
expected to boom in the coming years. Consequently, the development of more
efficient qualitative and quantitative methods for the analysis of these compounds
is required [11].
Cannabinoids may be classified into three groups based on their source of pro-
duction, viz., endocannabinoids, phytocannabinoids and synthetic cannabinoids
[12]. There is an extensive list of these compounds, hence only some of them are
depicted in Figure 1.
2.1 Endocannabinoids
Endocannabinoids (ECs) are defined as endogenous lipids that are involved in
many physiological and pathological conditions, regulating neurological disorders.
They are characterized by their cannabimimetic features, activating the cannabi-
noid receptors (CB1 and CB2) as well as other receptors. For this reason, the
development of reliable methodologies to determine ECs levels is mandatory in
order to understand the role of these lipid metabolites. Different ECs have been
widely analyzed by GC–MS and LC–MS, like arachidonoyl ethanolamide (ananda-
mide, AEA) and 2-arachidonyl glycerol (2-AG) in human biosamples, which are the
two most widely studied [13]. Additionally, other ECs like virodhamine and noladin
ether has been detected. These compounds present physiological properties compa-
rable to natural and synthetic exogenous cannabinoids. However, the main draw-
back found in their determination is their low concentration, acute instability of
some endogenous compounds as well as the limited sample availability. For this
reason, different extraction techniques like liquid–liquid extraction (LLE) or solid
phase extraction (SPE) have been used for the quantification of ECs from different
samples, to increase the analyte concentration. Moreover, microextraction
Figure 1.
Classification of cannabinoids based on their source of production.
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approaches like solid phase microextraction (SPME) have been employed in the ECs
analysis, reducing the required amount of sample [14].
Several strategies using GC–MS have been described in the literature for the
determination of ECs from biological samples [15–17]. In this regard, different
derivatization reagents like BSTFA or methyl ester of the methoxim dimethyiso-
propylsilyl (DMiPSi) have been employed, in order to increase the stability of these
compounds during their analysis. Additionally, different ionization modes, includ-
ing electron ionization (EI), positive chemical ionization (PCI) and negative chem-
ical ionization (NCI, also denoted as NICI, ECCI, ECNI and ECNICI) have been
utilized. Such is the case of the method reported by Kayacelebi et al., based on the
indirect evaluation of 2-AG by the analysis of arachidonic acid (AA) and prosta-
glandin E2 (PGE2), which are hydrolysis products of the EC. This approach employs
GC–MS and GC–MS/MS using the NCI mode. This technique provides enhanced
selectivity in comparison to EI since only analytes with high electron capture
capacity or high electron affinity may be ionized, thereby eliminating potential
sample matrix interferences and allowing detections at very low concentration
levels (ng/L). This consideration provides an advantage in contrast to LC–MS, since
sample matrix is usually one of the major issues in this methodology. In NCI, low
energy electrons (around 2 eV) are produced by collision of the reagent gas (gener-
ally methane, ammonia or carbon dioxide) with electrons emitted from the fila-
ment. The resulting electrons are captured by the analyte producing stable
molecular anions. Although only specified analytes fulfill the characteristics to be
used by this technique, derivatization processes provide wider applicability to this
unusual ionization mode. For instance, the perfluoro group presents high electron
affinity, being suitable for NCI. In this manner, an esterification process of AA and
PGE2 was accomplished using pentafluorobenzyl bromide (PFB-Br) as derivatiza-
tion agent, allowing the controlled fragmentation of both metabolites and accord-
ingly, resulting in a highly sensitive quantitative method [18]. Additionally, PCI has
been used for the determination of AEA by GC–MS using TMS as derivatization
agent. As with NCI, PCI is based on the generation of protonated molecules by
collision of the reagent gas with an electron emitted from the filament. The ionized
reagent gas reacts with the analyte, resulting in a positive adduct ion. In both PCI
and NCI, information about the molecular weight of the analyte is provide, unlike
EI where higher energy electrons collide with analytes creating fragmented positive
ions and other species. Even though this methodology may appear simpler, the
selectivity reached by NCI outweighs the benefits of PCI, as well as the weaknesses
of the technique itself, viz., dissociative reactions by high energy electrons, analyte
response suppression by oxygen or water contamination and affected reaction yield
and fragmentation behavior due to high ionization chamber temperature [19].
These strategies are summarized in Table 1.
Despite the fact that GC–MS has been extensively utilized to determine ECs
metabolites from biological samples, in the recent years, LC–MS/MS has become the
generally employed instrumentation in the analysis of ECs, being considered in this
sense the reference analytical technique. This preference may be attributed to
increased sensitivity and selectivity as well as high-throughput capability. In addi-
tion, derivatization processes of ECs may be avoided, which are laborious and time-
consuming [20].
2.2 Phytocannabinoids
Phytocannabinoids are naturally occurring cannabinoids found in the Cannabis
plant. These compounds present a similarity in their chemical structure since they
are constituted by a C21 structural feature with alterations in the length of their side
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Plant 20 mg 44 SCs — SPME HS-SPME- EI DB-5 ms 23 — — — — — [46]
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2-AG: 2-arachidonyl glycerol; AA: arachidonic acid; AEA: anandamide; AXS: anion exchange sorbent; BSTFA: N,O-bis (trimethylsilyl) trifluoroacetamide; CBC: cannabichromene; CBD: cannabidiol; CBDA: cannabidiolic acid;
CBDV: cannabidivarin; CBG: cannabigerol; CBGA: cannabigerolic acid; CBN: cannabinol; DMiPSi: methyl ester of the methoxim dimethyisopropylsilyl; EI: electron ionization; FID: flame ionization detector; GC: gas chromatography;
HCEE: hard cap espresso extraction; HFIP: hexafluoroisopropanol; IR: infrared; LLE: liquid–liquid extraction; MEPS: micro extraction by packed sorbent; MS: mass spectrometry; MSTFA: N-Methyl-N-(trimethylsilyl)
trifluoroacetamide; NAE: N-acylethanolamines; NCI: negative chemical ionization; PCI: positive chemical ionization; PEA: palmitoylethanolamide; PFB-Br: pentafluorobenzyl bromide; PFPA: pentafluoropropionic anhydride; PGE2:
prostaglandin E2; PHWE: pressurized hot water extraction; PI: photoionization; SBSE: stir bar sorptive extraction; SEA: stearoylethanolamide; SPE: solid phase extraction; SPME: solid phase microextraction; THC:
tetrahydrocannabinol; THCAA: tetrahydrocannabinolic acid A; TMCS: trimethylchlorosilane; QTOF: quadrupole time-of-flight; UADLLME: ultrasound-assisted dispersive liquid–liquid microextraction; UV/VUV: ultraviolet/vacuum
ultraviolet.
Table 1.





















chain (C1-C5) attached to the aromatic ring. Cannabigerolic acid (CBGA) is a
precursor molecule, which can be converted through a series of enzymatic reactions
into Δ9-tetrahydrocannabinolic acid (Δ9-THCA), cannabidiolic acid (CBDA), or
cannabichromenic acid (CBCA). Acidic phytocannabinoids may be subsequently
decarboxylated into their corresponding active neutral form by decarboxylation
processes, losing a COOH group. This process may occur over time, under heating
or alkaline conditions [10]. Consequently, the previously mentioned cannabinoids
will be transformed into cannabigerol (CBG), Δ9-THC, cannabidiol (CBD) and
cannabichromene (CBC). All these cannabinoids are characterized by a composition
of five carbon atoms in their side chain. Additional compounds have been detected
varying the length of their side chain, thereby varinoids compounds, such as
tetrahydrocannabivarinic acid (THCVA), cannabidivarinic acid (CBDVA),
cannabidivarin (CBDV) and tetrahydrocannabivarin (THCV) are naturally pro-
duced in the plant, with a three-term alkyl chain. Some other compounds, like Δ8-
tetrahydrocannabinol (Δ8-THC), cannabinol (CBN), cannabicyclol (CBL),
cannabinolic acid (CBNA), and cannabicyclolic acid (CBLA) have also been
reported. Additionally, the exposition to environmental agents like oxygen may
lead to the alteration of these compounds. The oxidative degradation of Δ9-THC to
CBN under oxygen exposition is a representative example of this condition [21].
Currently, almost 150 phytocannabinoids have been detected in Cannabis plant,
although most of them have never been isolated or characterized. Therefore, the list
is still under construction since new cannabinoids are continually being discovered
[22]. Recently, new phytocannabinoids have been detected, viz., cannabidibutol
(CBDB) and Δ9-tetrahydrocannabutol (Δ9-THCB), characterized by four carbon
atoms in their side chain, as well as cannabidiphorol (CBDP) and tetrahydrocanna-
biphorol (Δ9-THCP), being the seven-term homologs of CBD and Δ9-THC, respec-
tively [23]. Δ9-THCP proved to be as active as Δ9-THC but at lower doses, being
necessary further analyses to evaluate the pharmacological effect of this potent
phytocannabinoid.
For many years, Cannabis has had a negative connotation due to the psychotro-
pic effects associated with ∆9-THC. However, researchers have been working for a
long time against this situation due to the beneficial health components found in the
plant. All the bioactive components contribute in different manner to health, being
used as treatment against different diseases. Among them, CBD has been the most
widely studied phytocannabinoid, since it presents a series of medical properties
like antioxidant, anti-inflammatory, antibacterial, anti-proliferative and
neuroprotective effects. However, all this flood of information has diverted the
attention from some other minor cannabinoids with more remarkable and interest-
ing characteristics. In this sense, CBDV, CBG and Δ9-THCV have been barely
investigated since the low concentration of these cannabinoids in the plant hinder
their isolation for further studies. Nevertheless, there is evidence of the anti-
inflammatory and anti-proliferative properties of CBG and CBC, together with a
significant antibacterial activity [24, 25]. Thus, the genetic selection of Cannabis
varieties rich in other minor phytocannabinoids would confer the opportunity of
extract these compounds.
From a medical point of view, the administration of these compounds has been
normally accomplished by Cannabis oil extracts, which are produced from dried
Cannabis sativa L. inflorescences incorporated in common edible oils (e.g., olive or
sunflower), sometimes using these oils as extraction media [26]. Thus, Cannabis
extraction has been thoroughly studied to obtain highly concentrated content of
cannabinoids and other beneficial components. Different organic solvents like eth-
anol, methanol, acetone, or hexane have been utilized for this purpose, although
more natural approaches, like water, have been also evaluated. An exhaustive
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control of the potency as well as the standardization of different plant batches may
be accomplished to guarantee the correct dosage of phytocannabinoids in the final
oil. Accordingly, analyses of the extracts resulted of the maceration in olive oil have
been performed by GC coupled to flame ionization detector (FID) and GC–MS, as a
way of comparison (see Table 1). Results were comparable in terms of precision,
accuracy and linearity [27]. Recently, an innovative and rapid method has been
reported to the extraction of cannabinoids, using the hard cap espresso extraction
(HCEE) methodology coupled to GC–MS [28]. This approach allows the quantita-
tive extraction of THC, CBD and CBN from seized Cannabis samples in only 40 s,
using 100 mL of isopropanol and GC–MS determination. The obtained results were
compared with those acquired by the ultrasound-assisted extraction (UAE) refer-
ence method, being both approaches statistically comparable. Similarly, a green
extraction method, pressurized hot water extraction (PHWE), has been used to
extract cannabinoid compounds from Cannabis sativa L. seeds. This technique,
based on the supercritical fluid extraction, is an alternative to CO2 that enables
the extraction of polar and semi-polar bioactive compounds from Cannabis seeds.
In this case, GCxGC-TOF-MS methodology allowed the identification of
cannabinoids without the need of using standards [29]. Considering that these
concentrated cannabinoids extracts will be used in the pharmaceutical industry, an
exhaustive control is mandatory to ensure consumer safety according to the GMP
system [30].
These compounds are metabolized in the organism after consumption, being
possible the detection of their metabolites. Analysis of these chemical by-products is
an excellent solution to distinguish between passive drug exposure and active con-
sumption. In this sense, Δ9-THC is rapidly adsorbed and metabolized to 11-nor-Δ9-
tetrahydrocannabinol-9-carboxylic acid (Δ9-THC-COOH) and 11-hydroxy-Δ9-THC
(11-THC-OH), using these compounds as Cannabis biomarkers of the psychoactive
form. However, the low concentration of these metabolites in biological samples
implies the use of high sensitive equipment like GC–MS/MS or LC–MS/MS as well
as the extraction and preconcentration of the analytes before the analysis, which is
time and solvent consuming, especially when liquid–liquid extraction (LLE) is
utilized [31]. Alternatives approaches to LLE has been reported, including anion
exchange sorbent (AXS) and SPME in combination with head space GC–MS (HS-
SPME-GC–MS) [32, 33].
Recently, Beike et al. reported an automated process of sample preparation,
which includes extraction, clean up and derivatization of cannabinoids, prior to GC-
EI-MS/MS. The determination of THC as well as its metabolites Δ9-THC-COOH and
11-THC-OH in hair samples was accomplished using a SPE cartridge attached to the
module of the MultiPurposeSampler (MPS) autosampler from GERSTEL, allowing
the complete automation of the extraction process with relative standard deviation
better than 7% [34]. In the same way, distinct GC ionization sources have been
applied to achieve enhanced sensitivity, like atmospheric pressure (AP) source. This
recently commercialized modality provides better ionization results than electron
ionization (EI) or chemical ionization (CI) sources, enhancing selectivity and, con-
sequently, sensitivity. AP source has been used for the quantitative determination
of cannabinoids in serum samples at trace levels [35]. This softer ionization tech-
nique is based on the ionization of compounds by corona discharge in the presence
of nitrogen, operating at atmospheric pressure. However, EI has been employed as
the common ionization source for the analysis of Cannabis. This modality is char-
acterized by its higher ionization energy, which produces extensive fragmentation
of the molecular ion, thus reducing the possibility of using the better known and
higher mass precursor ions (typically used in ESI-LC–MS) in selected reaction
monitoring mode (SRM) and, on the other hand, the presence of higher mass
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precursor ions in CI improves the potential for lower detection limits in CI SRM as
compared to EI SRM.
Phytocannabinoids have been widely analyzed by GC techniques, using pre-
dominantly FID and MS as detectors. One of the main shortcomings of the analysis
of these compounds by GC is the direct analysis of acidic phytocannabinoids, which
undergoes decarboxylation in the injector port due to the high temperatures. This
drawback can be avoided by derivatization processes, which increase the chemical
stability of the acidic compounds [9, 36]. For this reason, generally liquid chroma-
tography (LC) is preferred since derivatization step is avoided. Nevertheless,
greater sensitivity is reached with GC methods, still being the instrumental tech-
nique of choice. Franklin et al. reported the headspace derivatization of cannabi-
noids during HS-SPME step. To this end, 5 μL of derivatization reagent, MSTFA,
was inserted in a 20 mL sample vial with the aid of a vial insert. The presence of
MSTFA effectively derivatized the neutral cannabinoids enhancing the sensitivity
of the determination. However, an earlier derivatization of the acidic cannabinoids
is necessary since the performance of the headspace derivatization in this case was
not so effective [37].
An additional problem associated with the determination of cannabinoids by
GC–MS is the difficulty to distinguish between isomers without compromising
analysis time. This is the case of Δ9-THC, which presents four isomers: Δ8 -THC,
CBD, CBC, and CBL. Some strategies have been developed to overcome this prob-
lem, like the inclusion of two-dimensional GC (GCxGC) technique, which allows
the identification of complex samples, identifying biomarkers and cannabinoid iso-
mers [5]. In this case, stir bar sorptive extraction (SBSE) coated with poly-
(dimethylsiloxane) (PDMS) was utilized allowing the preconcentration of a wide
range of compounds with different volatilities. The retained metabolites were
directly desorbed in a GCxGC–MS system, resulting in a green analytical treatment
procedure. Although isomers resolution is solved with this system, analysis time
remains a problem since it is necessary to perform an extraction step for at least
60 min in addition to the 93 min per run. Nevertheless, the automatization of the
process may reduce human involvement and therefore systematic and random
errors could be limited. Conversely, the use of GC with vacuum UV spectroscopy
(VUV) could be a potential solution since differentiation among isomers may be
solved in shorter analysis times (<15 min). This technology analyses compounds in
the UV/VUV spectral range (120–240 nm) and is based on the excitation of chem-
ical bonds [11]. This strategy has been utilized for the determination of different
cannabinoids and their metabolites. The deconvolution of co-elution peaks allows
the reduction of the chromatographic time and therefore the analysis process.
However, this solution constitutes an improvement at the expense of sensitivity.
2.3 Synthetic cannabinoids
Synthetic cannabinoids (SCs) are a class of designed drugs that simulates the
effects of ∆9-THC towards cannabinoid receptors. Originally, the synthesis of these
compounds was intended with therapeutic purposes as a treatment of pain, being





methanone) and HU-210 (1,1-Dimethylheptyl-11-hydroxy-tetrahydrocannabinol),
commercialized in many European and US countries as ‘Spice’, among others. Some
of these cannabinoids are represented in Figure 1. There is a real risk consuming
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this type of drugs since their chronic abuse often leads to dangerous side effects as
well as toxicity and, even in some cases, resulting in death. In addition, new psy-
choactive substances are constantly emerging, presenting unknown and unexpected
effects. Consequently, further research is needed in this field entailing an enormous
challenge, since it requires a continual actualization of the analytical techniques
with the lack of available chemical reference standards. Chromatographical tech-
niques like GC has become an important tool in this field to determine the preva-
lence and to assess the risks of SCs [39]. An additional problem is related to the
chemical structure of these compounds, which is not well defined and therefore
hinder even further their detection. While some of them, denoted as classical SCs,
are structurally like natural cannabinoids, others named nonclassical and hybrid
SCs present different structural features. For this reason, researchers studied frag-
mentation pathways of these compounds to facilitate their identification by GC–MS
[40]. Although this process appears simple, some compounds result in similar mass
spectra, impeding the identification of the SCs. Tandem and high-resolution MS
may solve this obstacle, but generally, these equipments are not easily accessible.
Therefore, more economically feasible solutions are needed. One cost-effective
solution to this issue could be the utilization of different ionization modes, such as
photoionization (PI). Akatsu et al. reported the utilization of GC-PI-MS for the
identification of 62 SCs. This technique allows the detection of stable neutral com-
pounds with low ionization threshold using a radical cation produced by ultraviolet
light radiation which traps an electron from the target molecule. This effect is not
possible with EI, which is an adequate technique for relatively high ionization
threshold. In this way, with the combination of both ionization modes, it would be
possible the identification of SCs [41]. Additionally, alternative ionization sources
as cold-EI or CI have been described to overcome the SCs lability towards EI. These
techniques increase the abundance of molecular ions allowing the discrimination
between structurally-related compounds enhancing at the same time the limit of
detection (LOD) and quantification (LOQ) of the procedure (see Table 1) [42, 43].
Alternatively, the combination of the GC-EI-MS and GC-IR techniques allowed the
separation of six SCs regioisomers with excellent resolution results [44]. Addition-
ally, Umebachi et al. reported the combination of GC–MS using EI, PCI and NCI for
the structural elucidation and identification of different SCs in herbal products. The
fragmentation of the indole and indazole SC structures was monitored with the
different ionization modes, using methane as reagent gas. Although EI gives enough
information about the fragmentation pattern of the molecules, PCI and NCI provide
the [M+H]+ and [M-H] fragment ions, which could be used for the molecular
weight estimation [45].
On the other hand, complexity of samples may cause a reduction in the sensi-
tivity of the determination as well as to affect the chromatographic system, partic-
ularly the stationary phase of the analytical column. Consequently, routine methods
for identification of new psychoactive substances generally require quick, cheap
and simple extraction methods. Scientists have been working for many years
addressing this deficiency, providing new and upgraded extraction techniques to
remove the undesired sample interferences. Mercieca et al. have developed a simple
method to determine SCs and their metabolites in urine and blood samples. The
procedure included ultrasound-assisted liquid–liquid microextraction (UALLME)
and silylation derivatization coupled with GC–MS, being able to effectively identify
36 SCs and related metabolites with acceptable accuracy and precision results [7]. In
the same way, HS-SPME-GC/MS has been utilized to determine 40 SCs in herbal
mixtures as well as blood samples. The utilization of the SPME methodology allows
the reduction of blood sample volume to 500 μL, of great advantage in the forensic
analysis [46]. Recently, a new configuration using microextraction by packed
12
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sorbents (MEPS) to isolate five SCs from oral biofluids has been reported. This
method allows the quantification of these compounds in the low μg/L level by
GC-EI-MS, requiring just 500 μL of sample. MEPs configuration allows the
potential automatization of the process for routine analysis, improving the method
precision [47].
3. Terpenes
Apart from cannabinoids, Cannabis sativa L. is rich in terpene compounds, being
the major components of the Cannabis essential oils (EO). In the same way to
cannabinoids, hemp EO is secreted by glandular trichomes, which are presented in
the leaves and inflorescences of the plant. Terpenes represent the volatile fraction,
responsible for the characteristic smell of the plant [48]. Moreover, their health
benefits and antimicrobial and insecticidal properties have recently increased the
interest in the hemp EO. In addition, some studies reveal a synergistic action of
terpenes with cannabinoids, known as ‘entourage effect’, in the treatment of pain,
inflammation, depression, anxiety, addiction, epilepsy, cancer, and infections [4].
For this reason, more than 120 terpenes have been identified in Cannabis using GC-
FID and GC–MS. Furthermore, recent studies have revealed that the terpenoid
profile is a useful tool since compositional differences may be used to distinguish
between Cannabis cultivars that have similar cannabinoid content [49, 50]. Ter-
penes may be classified according to their number of carbon atoms and the isoprene
residues present in their structure as monoterpenes, diterpenes, triterpenes and
sesquiterpenes, being the monoterpenes α-pinene, β-myrcene and α-terpinolene,
and the sesquiterpenes β-caryophyllene and α-humulene the most abundant com-
pounds in C. sativa L (Figure 2).
Some strategies have been developed to elucidate the terpene profile in Cannabis
samples (see Table 2). This is the case of HS, coupled in some cases to SPME
[51, 52], and two-dimensional GCxGC [5]. Meiri et al. reported the simultaneous
analysis and quantification of 93 terpenoids in Cannabis inflorescences by static
headspace (SHS) coupled to GC–MS/MS at very low μg/L level [53]. SHS allows the
direct analysis of plant materials without sample treatment, which may affect
negatively to the terpenoid content. Additionally, direct injection of these complex
sample matrices is not recommended because coextracted interferences potentially
hinder terpenes determination. On the other hand, low-volatility compounds may
Figure 2.
The most abundant terpenes in Cannabis sativa L.
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100 mg — SPME HS-SPME-
GC–MS
EI Rtx-Wax 33 — — — — [52]
Inflorescences 5 mg — — SHS-GC–
MS/MS





























63 — — — — [55]
EI: electron ionization; EO: essential oil; FID: flame ionization detector; GC: gas chromatography; HS: head space; MS: mass spectrometry; MSTFA: N-Methyl-N-(trimethylsilyl)trifluoroacetamide; SHS:
static head space; SPME: solid phase microextraction; TMCS: trimethylchlorosilane.
Table 2.




















be retained in the injection port requiring more frequent maintenance [54]. Never-
theless, some strategies have been reported by direct injection using fast-GC-FID,
analyzing 29 terpenes and CBD from leaf samples in less than 16 min [2]. Despite
higher amount of sample is used in the later approach, the sensitivity is affected,
being approximately 10-fold lower than the GC–MS/MS procedure, probably due to
the utilization of different detection systems. On the other hand, the precision is
improved after the derivatization with MSTFA:TMCS.
Sample storage plays an important role in the terpene analysis, having mono-
terpenes a tendency to evaporate more easily than sesquiterpenes. For this reason,
special attention is required when analyzing these compounds. Some strategies have
been evaluated such as using frozen samples instead of dried plant material or
dynamic maceration at room temperature of plant inflorescences, providing excel-
lent results [9, 55]. Additionally, oxygenated terpenoids, because of the presence of
light or oxygen, may reveal some problems during plant storage and processing.
Thus, the terpene profile provides interesting information about the EO or the
starting plant material, such as the aging of the product, bad storage conditions or
quality and breeding conditions. Terpene analysis provides these kind of informa-
tion to take into consideration [25].
4. Other compounds
As it was described before, Cannabis sativa L. is mainly composed by cannabi-
noids and terpenes. However, some studies were focused on the determination of
other minor compounds, like fatty acids and carbohydrates (see Table 3). Devi
et al. reported the analysis of hemp oil by GC–MS for the determination of fatty
acids and other compounds to be exploitable as biofuel [56]. In their study, different
solvent extraction techniques were evaluated, such as supercritical fluid extraction
(SFE), Soxhlet (SOX) and percolation (PER), among others. Although SOX is the
best energy-efficient process, SFE is preferable in terms of purity of the obtained
oil. However, alternative strategies might be implemented since large amount of
solvents and extended extraction times make this approach economically and envi-
ronmentally unattractive. On the other hand, an innovative method using hemp
steam treatment has been described [57]. Steam and hot water were used to extract
different compounds from diverse parts of hemp plants, such as stalk and leaves,
using LLE and GC–MS for this purpose. The procedure allows the identification of
several compounds like carbohydrates, fatty acids and aldehydes, among others.
This procedure represents an improvement in comparison to the Devi et al.
approach since analysis time is greatly reduced as well as solvent consumption.
Additionally, Delgado-Povedano et al. reported two analytical platforms (GC-TOF/
MS) and (LC-QTOF-MS/MS) for the untargeted characterization of Cannabis
extracts, identifying a wide range of families including lipids, flavonoids, and amino
and organic acids, among others, in multiples varieties of medicinal Cannabis [50].
The GC platform allowed the identification of 134 compounds in plant extracts in
comparison with the 46 compounds identified by LC.
In the countries where Cannabis has been legalized for medical purposes, the
governing agencies have established a series of strict regulations to guarantee the
quality, safety, and usefulness of Cannabis products. Generally, these guidelines
include the necessary quality control of pesticides, residual solvents, mycotoxins,
heavy metals, and microbes to agree with the GMP system. The first two contami-
nants are widely controlled in the pharmaceutical industry using GC methodologies
for their analysis. Short- and long-term adverse health effects are associated with the
exposure to these contaminants through consumption of Cannabis products [58].
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Sample treatment Instrumental technique Ref.
Sample Amount of
sample




Seed oil — Fatty acids — SFE/SOX/PER/ULT/
UTS/STU
GC–MS EI DB-5MS 60 [56]
Plant 2 mg Carbohydrates TMCS:HMDS LLE GC–MS EI HP-5 ms 28 [57]
Plant (leaves and
inflorescences)
100 mg Untargeted BSTFA +
TMCS
— GC-TOF EI DB-5MS-UI 53 [50]





Concentrated samples 100 mg Residual
solvents
— — HS-GC–MS EI SHRXI- 5MS 7 [60]
BSTFA: N,O-bis (trimethylsilyl) trifluoroacetamide; EI: electron ionization; GC: gas chromatography; HMDS: hexamethyldisilzane; HS: head space; LLE: liquid–liquid extraction;MS:mass spectrometry;
PER: percolation; QTOF: quadrupole time-of-flight; SFE: supercritical fluid extraction; SOX: Soxhlet; STU: Soxhlet treated ultrasonication: TMCS: trimethylchlorosilane; ULT: ultrasonication; UTS:
ultrasonication treated Soxhlet.
Table 3.




















In the cultivation of Cannabis, pesticides are often applied to repel or eliminate
unwanted pests. Despite the fact that this activity is required from an agricultural
point of view, it may also affect human health due to the remain of pesticide
residues in Cannabis and its derived products. For this reason, much attention has
been focused on analyzing these compounds to guarantee the safety and quality of
the final pharmaceutical drug. Different analytical methods have been applied to
this end, being GC–MS one of the most common encountered techniques [21].
However, one of the main limitations associated with Cannabis pesticide analysis is
the low-level concentration of these pollutants in the sample in comparison to
cannabinoid and terpene content. For this reason, different methods have been
reported to remove potential interferences and enable the analysis of residual pes-
ticides, as LLE, SPE, SPME and quick, easy, cheap, effective, rugged, and safe
(QuEChERS) [58]. Conversely, in the last years, some researchers have evaluated
the potential of Cannabis EO as botanical insecticide. The toxicity of these products
has been tested with different insect pests like aphids and houseflies, among others
[51, 59]. In this way, the exploitation of hemp by-products represents an opportu-
nity of creating a circular economy.
In the analysis of products derived from Cannabis, which is generally
manufactured from extracts obtained with organic solvents, there are not many
publications dealing with residual solvents, despite the high health risk associated
with these contaminants. Probably, this is linked to the relatively recent legalization
of the medical use of Cannabis. As a matter of fact, Raber et al. have reported the
use of HS-GC–MS for the qualitative analysis of these impurities in cannabinoid
concentrates [60] but it would seem plausible to think that the scarcity of recent
scientific publications derives from the existence of official directions for the quan-
tification of such residues, such as national and international alimentary codices and
pharmacopeias.
5. Conclusions
Gas chromatography is a well-established tool in the Cannabis sector. Owing to
the extraordinary health benefits of the bioactive compounds of Cannabis sativa L.,
reliable methods to quantify them are required for quality assurance. Additionally,
cannabinoid and terpenoid profiles provide useful information to distinguish
between Cannabis cultivars. Furthermore, this technique is utilized in the fight
against the illegal recreational use of Cannabis, detecting ∆9-THC and their metab-
olites in different biological samples and identifying new synthetic cannabinoids.
For this reason, several analytical platforms have been developed using different
modalities, such as (fast)-GC-FID, GC–MS, GC–MS/MS, GC-TOF/MS or GC-IR.
Among them, GC–MS is the most utilized technique probably due to their accessi-
bility as well as the quality of the results. Additionally, the features of this modality
may be easily modified changing the ionization source, which might enhance the
sensitivity and selectivity of the measurements. Thus, several ionization sources like
EI, PCI, NCI and AP have been utilized in the analysis of Cannabis. On the other
hand, although GC-TOF/MS is a more sophisticated technique, which is not as
easily accessible as GC–MS, some approaches employing this modality have been
already published allowing the untargeted analysis of Cannabis metabolites.
Regarding the complex chemical composition of Cannabis plant, different strategies
have been performed avoiding matrix effect and solving simultaneously low con-
centration, and chromatographic resolution problems in some cases. In addition,
different extraction techniques have been utilized to determine Cannabis metabo-
lites in different matrixes. Microextraction techniques like SPME, SBSE or MEPS
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have been applied, which involve an advantage concerning other extraction modal-
ities since generally solvent and time consuming is minimized. In this sense, there
are an extensive range of possibilities to overcome the different problems that may
emerge in the analysis of Cannabis. Conversely, although sometimes GC approaches
are non-preferred in order to avoid time-consuming derivatization steps, this pro-
cess allows the analysis of instable compounds. This is the case of acidic cannabi-
noids, which generally are subjected to silylation processes to avoid decarboxylation
in the injection port of the GC. Additionally, derivatization procedures improve the
chromatographic resolution as well as the peak shape of analytes, enhancing ana-
lytical features like sensitivity and reproducibility.
Conflict of interest
The authors declare no conflict of interest.
Author details
María Teresa García-Valverde*, Verónica Sánchez de Medina, Verónica Codesido,
Jesús Hidalgo-García and Carlos Ferreiro-Vera
Phytoplant Research S.L., The Science and Technology Park of Córdoba, Rabanales
21, Córdoba, Spain
*Address all correspondence to: mt.garcia@phytoplant.es
© 2020TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
18
Recent Advances in Gas Chromatography
References
[1] I. J. Flores-Sanchez and A. C. Ramos-
Valdivia, A review from patents inspired
by the genus Cannabis, vol. 16, no. 4.
Springer Netherlands, 2017.
[2] F. Bakro, M. Jedryczka, K. Wielgusz,
B. Sgorbini, R. Inchingolo, and V.
Cardenia, “Simultaneous determination
of terpenes and cannabidiol in hemp
(Cannabis sativa L.) by fast gas
chromatography with flame ionization
detection,” J. Sep. Sci., vol. 43, pp. 2817–
2826, 2020, doi: 10.1002/
jssc.201900822.
[3]A. Leghissa, Z. L. Hildenbrand, F. W.
Foss, and K. A. Schug, “Determination
of cannabinoids from a surrogate hops
matrix using multiple reaction
monitoring gas chromatography with
triple quadrupole mass spectrometry,” J.
Sep. Sci., vol. 41, no. 2, pp. 459–468,
2018, doi: 10.1002/jssc.201700946.
[4]D. Jin, S. Jin, Y. Yu, C. Lee, and J.
Chen, “Classification of Cannabis
Cultivars Marketed in Canada for
Medical Purposes by Quantification of
Cannabinoids and Terpenes Using
HPLC-DAD and GC-MS,” J. Anal.
Bioanal. Tech, vol. 08, no. 01, p. 2, 2017,
doi: 10.4172/2155-9872.1000349.
[5] F. Franchina, L. Dubois, and J.-F.
Focant, “In-Depth Cannabis Multiclass
Metabolite Profiling Using Sorptive
Extraction and Multidimensional Gas
Chromatography with Low- and High-
Resolution Mass Spectrometry,” Anal.
Chem., vol. 92, pp. 10512–10520, 2020,
doi: 10.1021/acs.analchem.0c01301.
[6] V. Cardenia,T. gallina Toschi, S.
Scappini, R. C. Rubino, and M. T.
Rodriguez-Estrada, “Development and
validation of a Fast gas
chromatography/mass spectrometry
method for the determination of
cannabinoids in Cannabis sativa L,” J.
Food Drug Anal., vol. 26, no. 4, pp.
1283–1292, 2018, doi: https://doi.org/
10.1016/j.jfda.2018.06.001.
[7]G. Mercieca, S. Odoardi, S. Mestria,
M. Cassar, and S. Strano-Rossi,
“Application of ultrasound-assisted
liquid–liquid microextraction coupled
with gas chromatography and mass
spectrometry for the rapid
determination of synthetic cannabinoids
and metabolites in biological samples,”
J. Sep. Sci., 2020, doi: 10.1002/
jssc.202000181.
[8] B. Fodor and I. Molnár-Perl, “The
role of derivatization techniques in the
analysis of plant cannabinoids by gas
chromatography mass spectrometry,”
TrAC Trends Anal. Chem., vol. 95, pp.
149–158, 2017, doi: https://doi.org/
10.1016/j.trac.2017.07.022.
[9] T. Béres et al., “Intralaboratory
comparison of analytical methods for
quantification of major
phytocannabinoids,” Anal. Bioanal.
Chem., pp. 3069–3079, 2019, doi:
10.1007/s00216-019-01760-y.
[10]N. A. dos Santos et al., “Analysis of
isomeric cannabinoid standards and
cannabis products by UPLC-ESI-
TWIM-MS: a comparison with GC-MS
and GC GC-QMS,” J. Braz. Chem. Soc.,
vol. 30, no. 1, pp. 60–70, 2019.
[11] A. Leghissa, J. Smuts, C. Qiu, Z. L.
Hildenbrand, and K. A. Schug,
“Detection of cannabinoids and
cannabinoid metabolites using gas
chromatography with vacuum
ultraviolet spectroscopy,” Sep. Sci.
PLUS, vol. 1, no. 1, pp. 37–42, Jan. 2018,
doi: 10.1002/sscp.201700005.
[12] V. L. Alves, J. L. Gonçalves, J.
Aguiar, H. M. Teixeira, and J. S. Câmara,
“The synthetic cannabinoids
phenomenon: from structure to
toxicological properties. A review,” Crit.
Rev. Toxicol., vol. 50, no. 5, pp. 359–382,
19




[13] C. Lanz, J. Mattsson, F. Stickel, J.-F.
Dufour, and R. Brenneisen,
“Determination of the
Endocannabinoids Anandamide and 2-
Arachidonoyl Glycerol with Gas
Chromatography-Mass Spectrometry:
Analytical and Preanalytical Challenges
and Pitfalls,” Med. Cannabis
Cannabinoids, vol. 1, no. 1, pp. 9–18,
2018, doi: 10.1159/000489032.
[14] V. R. Acquaro Junior, G. A. Goméz-
Ríos, M. Tascon, M. E. Costa Queiroz,
and J. Pawliszyn, “Analysis of
endocannabinoids in plasma samples by
biocompatible solid-phase
microextraction devices coupled to mass
spectrometry,” Anal. Chim. Acta, vol.
1091, pp. 135–145, 2019, doi: 10.1016/j.
aca.2019.09.002.
[15] T. Obata, Y. Sakurai, Y. Kase, Y.





(8-epiprostaglandin F2α) by gas
chromatography-mass spectrometry-
selected ion monitoring for medical
samples,” J. Chromatogr. B Anal.
Technol. Biomed. Life Sci., vol. 792, no. 1,
pp. 131–140, 2003, doi: 10.1016/S1570-
0232(03)00311-8.
[16] S. Hardison, S. T. Weintraub, and A.
Giuffrida, “Quantification of
endocannabinoids in rat biological
samples by GC/MS: Technical and
theoretical considerations,”
Prostaglandins Other Lipid Mediat., vol.
81, no. 3–4, pp. 106–112, 2006, doi:
10.1016/j.prostaglandins.2006.08.002.
[17]G. G. Muccioli and N. Stella, “An
optimized GC-MS method detects
nanomolar amounts of anandamide in
mouse brain,” Anal. Biochem., vol. 373,
no. 2, pp. 220–228, 2008, doi: 10.1016/j.
ab.2007.09.030.
[18] A. A. Kayacelebi et al., “Cross-
validated stable-isotope dilution GC–MS
and LC–MS/MS assays for
monoacylglycerol lipase (MAGL)
activity by measuring arachidonic acid
released from the endocannabinoid 2-
arachidonoyl glycerol,” J. Chromatogr. B
Anal. Technol. Biomed. Life Sci., vol.
1047, pp. 151–159, 2017, doi: 10.1016/j.
jchromb.2016.08.004.
[19] J. Keereetaweep and K. D.
Chapman, “Lipidomic analysis of
endocannabinoid signaling: Targeted
metabolite identification and
quantification,” Neural Plast., vol. 2016,
2016, doi: 10.1155/2016/2426398.
[20] C. Marchioni, I. D. de Souza, V. R.
Acquaro, J. A. de Souza Crippa, V.
Tumas, and M. E. C. Queiroz, “Recent
advances in LC-MS/MS methods to
determine endocannabinoids in
biological samples: Application in
neurodegenerative diseases,” Anal.
Chim. Acta, vol. 1044, pp. 12–28, 2018,
doi: 10.1016/j.aca.2018.06.016.
[21] S. N. Atapattu and K. R. D. Johnson,
“Pesticide analysis in cannabis
products,” J. Chromatogr. A, vol. 1612, p.
460656, 2020, doi: 10.1016/j.
chroma.2019.460656.
[22] J. Basas-Jaumandreu and F. X. C. De
Las Heras, “GC-MS Metabolite Profile
and Identification of Unusual
Homologous Cannabinoids in High
Potency Cannabis sativa,” Planta Med.,
vol. 86, no. 5, pp. 338–347, 2020, doi:
10.1055/a-1110-1045.
[23] C. Citti et al., “A novel
phytocannabinoid isolated from
Cannabis sativa L. with an in vivo
cannabimimetic activity higher than
Δ9-tetrahydrocannabinol: Δ9-
Tetrahydrocannabiphorol,” Sci. Rep.,
vol. 9, no. 1, pp. 1–13, 2019, doi:
10.1038/s41598-019-56785-1.
[24] R. Franco et al., “Pharmacological
potential of varinic-, minor-, and acidic
20
Recent Advances in Gas Chromatography
phytocannabinoids,” Pharmacol. Res.,
vol. 158, 2020, doi: 10.1016/j.
phrs.2020.104801.
[25] R. Iseppi et al., “Chemical
characterization and evaluation of the
antibacterial activity of essential oils
from fibre-type Cannabis sativa L.
(Hemp),” Molecules, vol. 24, no. 12, p.
2302, 2019.
[26]N. Fernández, L. J. Carreras, R. A.
Larcher, A. S. Ridolfi, and P. N. Quiroga,
“Quantification of Cannabinoids in
Cannabis Oil Using GC/MS: Method
Development, Validation, and
Application to Commercially Available
Preparations in Argentina,” Planta
Medica Int. Open, vol. 07, no. 02, pp.
e81–e87, 2020, doi: 10.1055/a-1155-6613.
[27] A. Casiraghi et al., “Extraction
Method and Analysis of Cannabinoids in
Cannabis Olive Oil Preparations,”
Planta Med., vol. 84, no. 4, pp. 242–249,
2018, doi: 10.1055/s-0043-123074.
[28] K. Leiman, L. Colomo, S. Armenta,
M. de la Guardia, and F. A. Esteve-
Turrillas, “Fast extraction of
cannabinoids in marijuana samples by
using hard-cap espresso machines,”
Talanta, vol. 190, pp. 321–326, 2018,
doi: https://doi.org/10.1016/j.talanta
.2018.08.009.
[29] Y. Nuapia, H. Tutu, L. Chimuka,
and E. Cukrowska, “Selective Extraction
of Cannabinoid Compounds from
Cannabis Seed Using Pressurized Hot
Water Extraction,” Molecules, vol. 25, p.
1335, 2020.
[30] R. Pavlovic et al., “Quality traits of
‘cannabidiol oils’: cannabinoids content,
terpene fingerprint and oxidation
stability of European commercially
available preparations,” Molecules, vol.
23, no. 5, p. 1230, 2018.
[31] I. Angeli, S. Casati, A. Ravelli, M.
Minoli, and M. Orioli, “A novel single-
step GC–MS/MS method for
cannabinoids and 11-OH-THC
metabolite analysis in hair,” J. Pharm.
Biomed. Anal., vol. 155, pp. 1–6, 2018,
doi: 10.1016/j.jpba.2018.03.031.
[32]A. Gasse, H. Pfeiffer, H. Köhler, and
J. Schürenkamp, “Development and
validation of a solid-phase extraction
method using anion exchange sorbent
for the analysis of cannabinoids in
plasma and serum by gas
chromatography-mass spectrometry,”
Int. J. Legal Med., vol. 130, no. 4, pp.
967–974, 2016, doi: 10.1007/s00414-
016-1368-6.
[33]G. de O. Silveira, S. Loddi, C. D. R.
de Oliveira, A. D. Zucoloto, L. V. G.
Fruchtengarten, and M. Yonamine,
“Headspace solid-phase microextraction
and gas chromatographymass
spectrometry for determination of
cannabinoids in human breast milk,”
Forensic Toxicol., vol. 35, no. 1, pp. 125–
132, 2017, doi: 10.1007/s11419-016-
0346-5.
[34] T. Kieliba, O. Lerch, H. Andresen-
Streichert, M. A. Rothschild, and J.
Beike, “Simultaneous quantification of
THC-COOH, OH-THC, and further
cannabinoids in human hair by gas
chromatography–tandem mass
spectrometry with electron ionization
applying automated sample
preparation,” Drug Test. Anal., vol. 11,
no. 2, pp. 267–278, Feb. 2019, doi:
10.1002/dta.2490.
[35] R. Gottardo, D. Sorio, M. Ballotari,
and F. Tagliaro, “First application of
atmospheric-pressure chemical
ionization gas chromatography tandem
mass spectrometry to the determination
of cannabinoids in serum,” J.
Chromatogr. A, vol. 1591, pp. 147–154,
2019, doi: https://doi.org/10.1016/j.ch
roma.2019.01.041.
[36] E. A. Ibrahim et al., “Determination
of Acid and Neutral Cannabinoids in
Extracts of Different Strains of Cannabis
sativa Using GC-FID,” Planta Med., vol.
21
Exploring the Mysteries of Cannabis through Gas Chromatography
DOI: http://dx.doi.org/10.5772/intechopen.94903
84, no. 4, pp. 250–259, 2018, doi:
10.1055/s-0043-124088.
[37] T. Franklin, L. Perry, W. Shih, and J.
Yu, “Detection of phytocannabinoids
from buccal swabs by headspace solid
phase microextraction – gas
chromatography / mass spectrometry,”
Anal. Methods, vol. 10, pp. 942–946,
2018, doi: 10.1039/C7AY02996A.
[38]M. S. Castaneto, A. Wohlfarth, N. A.
Desrosiers, R. L. Hartman, D. A.
Gorelick, and M. A. Huestis, “Synthetic
cannabinoids pharmacokinetics and
detection methods in biological
matrices,” Drug Metab. Rev., vol. 47, no.
2, pp. 124–174, Apr. 2015, doi: 10.3109/
03602532.2015.1029635.
[39] L. N. Al-Eitan, A. S. Asa’ad, A. K. H.
Battah, and H. A. Aljamal, “Application
of Gas Chromatography-Mass
Spectrometry for the Identification and
Quantitation of Three Common
Synthetic Cannabinoids in Seized
Materials from the Jordanian Market,”
ACS Omega, vol. 5, no. 8, pp. 4172–4180,
2020, doi: 10.1021/acsomega.9b03881.
[40] A. Namera, M. Kawamura, A.
Nakamoto, T. Saito, and M. Nagao,
“Comprehensive review of the detection
methods for synthetic cannabinoids and
cathinones,” Forensic Toxicol., vol. 33,
no. 2, pp. 175–194, 2015, doi: 10.1007/
s11419-015-0270-0.
[41]M. Akutsu, K. Sugie, and K. Saito,
“Analysis of 62 synthetic cannabinoids
by gas chromatography–mass
spectrometry with photoionization,”
Forensic Toxicol., vol. 35, no. 1, pp. 94–
103, 2017.
[42] E. Smolianitski-Fabian, E. Cohen,
M. Dronova, A. Voloshenko-Rossin, and
O. Lev, “Discrimination between closely
related synthetic cannabinoids by GC–
Cold–EI–MS,” Drug Test. Anal., vol. 10,
no. 3, pp. 474–487, Mar. 2018, doi:
10.1002/dta.2247.
[43] S. Gwak, L. E. Arroyo-Mora, and J.
R. Almirall, “Qualitative analysis of
seized synthetic cannabinoids and
synthetic cathinones by gas
chromatography triple quadrupole
tandem mass spectrometry,” Drug Test.
Anal., vol. 7, no. 2, pp. 121–130, Feb.
2015, doi: 10.1002/dta.1667.
[44] J. DeRuiter, F. Smith, Y. Abiedalla,
L. Neel, and C. R. Clark, “GC-MS and
GC-IR analysis of regioisomeric
cannabinoids related to 1-(5-
fluoropentyl)-3-(1-naphthoyl)-indole,”
Forensic Chem., vol. 10, pp. 48–57, 2018,
doi: https://doi.org/10.1016/j.forc
.2018.07.005.
[45] R. Umebachi et al., “Detection of
synthetic cannabinoids using GC-EI-
MS, positive GC-CI-MS, and negative
GC-CI-MS,” Int. J. Legal Med., vol. 131,
no. 1, pp. 143–152, 2017, doi: 10.1007/
s00414-016-1428-y.
[46] K. Saito et al., “Confirmation of
synthetic cannabinoids in herb and
blood by HS-SPME-GC/MS,” Forensic
Chem., vol. 13, p. 100156, 2019, doi: h
ttps://doi.org/10.1016/j.forc
.2019.100156.
[47] A. Sorribes-Soriano, J. Verdeguer,
A. Pastor, S. Armenta, and F. A. Esteve-
Turrillas, “Determination of Third
Generation Synthetic Cannabinoids in
Oral Fluids,” J. Anal. Toxicol., Jul. 2020,
doi: 10.1093/jat/bkaa091.
[48] E. A. Ibrahim et al., “Analysis of
terpenes in Cannabis sativa L. Using GC/
MS: method development, validation,
and application,” Planta Med., vol. 85,
no. 05, pp. 431–438, 2019.
[49] J. T. Fischedick, “Identification of
Terpenoid Chemotypes Among High
()- trans -Δ 9 - Tetrahydrocannabinol-
Producing Cannabis sativa L. Cultivars,”
Cannabis Cannabinoid Res., vol. 2, no. 1,
pp. 34–47, 2017, doi: 10.1089/
can.2016.0040.
22
Recent Advances in Gas Chromatography
[50]M. M. Delgado-Povedano, C.
Sánchez-Carnerero Callado, F. Priego-
Capote, and C. Ferreiro-Vera,
“Untargeted characterization of extracts
from Cannabis sativa L. cultivars by gas
and liquid chromatography coupled to
mass spectrometry in high resolution
mode,” Talanta, vol. 208, no. September
2019, p. 120384, 2019, doi: 10.1016/j.
talanta.2019.120384.
[51] R. Ascrizzi, M. Iannone, G. Cinque,
A. Marianelli, L. Pistelli, and G. Flamini,
“‘Hemping’ the drinks: Aromatizing
alcoholic beverages with a blend of
Cannabis sativa L. flowers,” Food Chem.,
vol. 325, no. November 2019, 2020, doi:
10.1016/j.foodchem.2020.126909.
[52] L. Calvi et al., “Comprehensive
quality evaluation of medical Cannabis
sativa L. inflorescence and macerated
oils based on HS-SPME coupled to GC–
MS and LC-HRMS (q-exactive
orbitrap®) approach,” J. Pharm.
Biomed. Anal., vol. 150, pp. 208–219,
2018, doi: 10.1016/j.jpba.2017.11.073.
[53] A. Shapira, P. Berman, K. Futoran,
O. Guberman, and D. Meiri, “Tandem
Mass Spectrometric Quantification of 93
Terpenoids in Cannabis Using Static
Headspace Injections,” Anal. Chem., vol.
91, no. 17, pp. 11425–11432, 2019, doi:
10.1021/acs.analchem.9b02844.
[54] T. D. Nguyen, S. Riordan-Short, T.
T. T. Dang, R. O’Brien, and M.




Headspace Sampling,” ACS Omega, vol.
5, no. 10, pp. 5565–5573, 2020, doi:
10.1021/acsomega.0c00384.
[55]M. Ternelli et al., “Innovative
methods for the preparation of medical
Cannabis oils with a high content of
both cannabinoids and terpenes,” J.
Pharm. Biomed. Anal., vol. 186, p.
113296, 2020, doi: 10.1016/j.
jpba.2020.113296.
[56] V. Devi and S. Khanam,
“Comparative study of different
extraction processes for hemp
(Cannabis sativa) seed oil considering
physical, chemical and industrial-scale
economic aspects,” J. Clean. Prod., vol.
207, pp. 645–657, 2019, doi: 10.1016/j.
jclepro.2018.10.036.
[57] T. Väisänen, P. Kilpeläinen, V.
Kitunen, R. Lappalainen, and L.
Tomppo, “Effect of steam treatment on
the chemical composition of hemp
(Cannabis sativa L.) and identification
of the extracted carbohydrates and
other compounds,” Ind. Crops Prod., vol.
131, no. February, pp. 224–233, 2019,
doi: 10.1016/j.indcrop.2019.01.055.
[58] C. B. Craven, N. Wawryk, P. Jiang,
Z. Liu, and X. Li, “Pesticides and trace
elements in cannabis : Analytical and
environmental challenges and
opportunities,” J. Environ. Sci., vol. 85,
pp. 82–93, 2019, doi: 10.1016/j.
jes.2019.04.028.
[59]G. Benelli et al., “The essential oil
from industrial hemp (Cannabis sativa
L.) by-products as an effective tool for
insect pest management in organic
crops,” Ind. Crops Prod., vol. 122, no.
February, pp. 308–315, 2018, doi:
10.1016/j.indcrop.2018.05.032.
[60] J. C. Raber, S. Elzinga, and C.
Kaplan, “Understanding dabs :
contamination concerns of cannabis
concentrates and cannabinoid transfer
during the act of dabbing,” vol. 40, no.
6, pp. 797–803, 2015.
23
Exploring the Mysteries of Cannabis through Gas Chromatography
DOI: http://dx.doi.org/10.5772/intechopen.94903
